Joseph V Moxon1, Rhondda E Jones2, Gerard Wong3, Jacquelyn M Weir3, Natalie A Mellett3, Bronwyn A Kingwell3, Peter J Meikle4, Jonathan Golledge5. 1. The Vascular Biology Unit, Queensland Research Centre for Peripheral Vascular Disease, James Cook University, Townsville, Queensland, Australia; The Australian Institute of Tropical Health and Medicine, James Cook University, Townsville, Queensland, Australia. 2. The Australian Institute of Tropical Health and Medicine, James Cook University, Townsville, Queensland, Australia. 3. Baker IDI Heart and Diabetes Research Institute, Melbourne, Victoria, Australia. 4. Baker IDI Heart and Diabetes Research Institute, Melbourne, Victoria, Australia. Electronic address: peter.meikle@baker.edu.au. 5. The Vascular Biology Unit, Queensland Research Centre for Peripheral Vascular Disease, James Cook University, Townsville, Queensland, Australia; The Australian Institute of Tropical Health and Medicine, James Cook University, Townsville, Queensland, Australia; Department of Vascular and Endovascular Surgery, The Townsville Hospital, Townsville, Queensland, Australia. Electronic address: jonathan.golledge@jcu.edu.au.
Abstract
BACKGROUND AND AIMS: Despite current best care, patients with peripheral artery disease (PAD) remain at high risk of myocardial infarction, and biomarkers to more accurately assess cardiovascular risk are needed. This study assessed the relationship between the serum lipidome and incident myocardial infarction in a cohort of PAD patients. METHODS: 265 PAD patients were followed up for a median of 23 months, during which 18 people suffered a myocardial infarction. Fasting serum concentrations of 332 lipid species were measured via mass spectrometry and their association with incident myocardial infarction was assessed via Cox regression. Secondary analyses investigated prognostic potential of specific lipid species. RESULTS: Total serum concentrations of alkyl-phosphatidylcholine and alkenylphospatidylcholine (plasmalogen) lipids were inversely associated with incident myocardial infarction after adjusting for multiple testing (hazards ratio (95% confidence intervals): 0.43 (0.24-0.74); p = 0.032; and 0.28 (0.14-0.56), p = 0.010, respectively). Specifically, 10 alkenylphosphatidylcholine species and 6 alkyl-phosphatidylcholine species were negatively associated with incident myocardial infarction after adjusting for traditional risk factors and correcting for multiple testing (hazards ratios ranging from 0.07 to 0.51, p < 0.05). Incorporation of serum phosphatidylcholine plasmalogen species PC(P-40:6) concentration within analyses designed to determine subsequent myocardial infarction incidence led to an improvement in predictive accuracy compared to traditional risk factors alone. CONCLUSIONS: Serum concentrations of phosphatidylcholine plasmalogens and alkyl-phosphatidylcholines were negatively associated with incident myocardial infarction and have potential to act as novel prognostic markers in at-risk populations.
BACKGROUND AND AIMS: Despite current best care, patients with peripheral artery disease (PAD) remain at high risk of myocardial infarction, and biomarkers to more accurately assess cardiovascular risk are needed. This study assessed the relationship between the serum lipidome and incident myocardial infarction in a cohort of PAD patients. METHODS: 265 PAD patients were followed up for a median of 23 months, during which 18 people suffered a myocardial infarction. Fasting serum concentrations of 332 lipid species were measured via mass spectrometry and their association with incident myocardial infarction was assessed via Cox regression. Secondary analyses investigated prognostic potential of specific lipid species. RESULTS: Total serum concentrations of alkyl-phosphatidylcholine and alkenylphospatidylcholine (plasmalogen) lipids were inversely associated with incident myocardial infarction after adjusting for multiple testing (hazards ratio (95% confidence intervals): 0.43 (0.24-0.74); p = 0.032; and 0.28 (0.14-0.56), p = 0.010, respectively). Specifically, 10 alkenylphosphatidylcholine species and 6 alkyl-phosphatidylcholine species were negatively associated with incident myocardial infarction after adjusting for traditional risk factors and correcting for multiple testing (hazards ratios ranging from 0.07 to 0.51, p < 0.05). Incorporation of serum phosphatidylcholine plasmalogen species PC(P-40:6) concentration within analyses designed to determine subsequent myocardial infarction incidence led to an improvement in predictive accuracy compared to traditional risk factors alone. CONCLUSIONS: Serum concentrations of phosphatidylcholine plasmalogens and alkyl-phosphatidylcholines were negatively associated with incident myocardial infarction and have potential to act as novel prognostic markers in at-risk populations.
Authors: Dong Hang; Oana A Zeleznik; Jiayi Lu; Amit D Joshi; Kana Wu; Zhibin Hu; Hongbing Shen; Clary B Clish; Liming Liang; A Heather Eliassen; Shuji Ogino; Jeffrey A Meyerhardt; Andrew T Chan; Mingyang Song Journal: Eur J Epidemiol Date: 2022-01-15 Impact factor: 12.434
Authors: Megan S Grace; Melissa F Formosa; Kiymet Bozaoglu; Audrey Bergouignan; Marta Brozynska; Andrew L Carey; Camilla Bertuzzo Veiga; Parneet Sethi; Francis Dillon; David A Bertovic; Michael Inouye; Neville Owen; David W Dunstan; Bronwyn A Kingwell Journal: Sci Rep Date: 2019-03-07 Impact factor: 4.379
Authors: Diana Thomas Manapurathe; Joseph Vaughan Moxon; Smriti Murali Krishna; Sophie Rowbotham; Frank Quigley; Jason Jenkins; Michael Bourke; Bernard Bourke; Rhondda E Jones; Jonathan Golledge Journal: J Am Heart Assoc Date: 2019-03-19 Impact factor: 5.501
Authors: Jonathan Golledge; Joseph V Moxon; Sophie Rowbotham; Jenna Pinchbeck; Frank Quigley; Jason Jenkins Journal: PLoS One Date: 2020-11-12 Impact factor: 3.240
Authors: Jonathan Golledge; Sophie Rowbotham; Ramesh Velu; Frank Quigley; Jason Jenkins; Michael Bourke; Bernie Bourke; Shivshankar Thanigaimani; Dick C Chan; Gerald F Watts Journal: J Am Heart Assoc Date: 2020-03-14 Impact factor: 5.501
Authors: Dylan R Morris; Tristan A Skalina; Tejas P Singh; Joseph V Moxon; Jonathan Golledge Journal: J Am Heart Assoc Date: 2018-10-16 Impact factor: 5.501